Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Simona Sacco; Gabriele S. Merki-Feld; Karen Lehrmann Ægidius; Johannes Bitzer; Marianne Canonico; Tobias Kurth; Christian Lampl; Øjvind Lidegaard; E. Anne MacGregor; Antoinette MaassenVanDenBrink; Dimos-Dimitrios Mitsikostas; Rossella Elena Nappi; George Ntaios; Per Morten Sandset; Paolo Martelletti; on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

doi:10.1186/s10194-018-0912-9

The Journal of Headache and Pain (Sep 2018)

Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Simona Sacco,
Gabriele S. Merki-Feld,
Karen Lehrmann Ægidius,
Johannes Bitzer,
Marianne Canonico,
Tobias Kurth,
Christian Lampl,
Øjvind Lidegaard,
E. Anne MacGregor,
Antoinette MaassenVanDenBrink,
Dimos-Dimitrios Mitsikostas,
Rossella Elena Nappi,
George Ntaios,
Per Morten Sandset,
Paolo Martelletti,
on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Affiliations

Simona Sacco: Department of Applied Clinical Sciences and Biotechnology, University of L’Aquila
Gabriele S. Merki-Feld: Department of Gynecology, Clinic for Reproductive Endocrinology, University Hospital
Karen Lehrmann Ægidius: Department of Neurology, Bispebjerg Hospital and University of Copenhagen
Johannes Bitzer: Department of Obstetrics and Gynecology, University Hospital of Basel
Marianne Canonico: Université Paris-Saclay, University Paris-Sud, UVSQ, CESP, Inserm UMRS1018
Tobias Kurth: Institute of Public Health, Charité – Universitätsmedizin Berlin
Christian Lampl: Headache Medical Center Seilerstaette Linz
Øjvind Lidegaard: Department of Obstetrics & Gynaecology, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen
E. Anne MacGregor: Centre for Neuroscience & Trauma, BICMS, Barts and the London School of Medicine and Dentistry
Antoinette MaassenVanDenBrink: Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus Medical Center Rotterdam
Dimos-Dimitrios Mitsikostas: Department of Neurology, Aeginition Hospital, National and Kapodistrian University of Athens
Rossella Elena Nappi: Research Centre for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS S. Matteo Foundation, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia
George Ntaios: Department of Medicine, University of Thessaly
Per Morten Sandset: Department of Haematology, Oslo University Hospital and University of Oslo
Paolo Martelletti: Department of Clinical and Molecular Medicine, Sapienza University of Rome
on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

DOI: https://doi.org/10.1186/s10194-018-0912-9
Journal volume & issue: Vol. 19, no. 1
pp. 1 – 2

Abstract

Read online

Following the publication of this article [1], the authors noticed that they incorrectly reported the Absolute risk of ischemic stroke in women aged 20 to 44 years in relation to the use of hormonal contraception and migraine status due to a miscalculation. They apologize for this misreported result.

Published in The Journal of Headache and Pain

ISSN: 1129-2369 (Print); 1129-2377 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine
Website: https://thejournalofheadacheandpain.biomedcentral.com/

About the journal